Filing Date | 
					T Date | 
					Ticker | 
										Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/20/23 16:29  | 3/16/23  | ACOR | Health | BioPrd | Biological Products, (No Diag | Cohen Ron | NY | DO | P,CEO | P.m | 13 | 0.6248 | 0 | 20 | 16 | 150 | D | ||||||||||||||
8/31/17 16:50  | 8/29/17  | ACOR | Health | BioPrd | Biological Products, (No Diag | Scopia Capital Management LP | NY | T | P | 14,730 | 19.23 | 0 | 766 | 10 | 8,475 | I | |||||||||||||||
6/20/17 15:52  | 6/16/17  | ACOR | Health | BioPrd | Biological Products, (No Diag | Cohen Ron | NY | DO | P,CEO | P | 339 | 16.95 | 0 | 20 | 4 | 555 | D | ||||||||||||||
2/17/06 15:48  | 2/15/06  | ACOR | Health | BioPrd | Biological Products, (No Diag | Steinmetz Michael | MA | D | P.d | 1,000 | 6.00 | 2 | 167 | 10 | 1,807 | I | 5 | -1 | -2 | -5 | -37 | -46 | 295 | ||||||||
2/17/06 15:46  | 2/15/06  | ACOR | Health | BioPrd | Biological Products, (No Diag | Fleming Standish | NY | D | P.d | 750 | 6.00 | 2 | 125 | 14 | 999 | I | 5 | -1 | -2 | -5 | -37 | -46 | 295 | ||||||||
2/17/06 15:46  | 2/15/06  | ACOR | Health | BioPrd | Biological Products, (No Diag | Panem Sandra Phd | NY | D | P.d | 250 | 6.00 | 2 | 42 | 6 | 750 | M | 5 | -1 | -2 | -5 | -37 | -46 | 295 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |